Chest最新文献

筛选
英文 中文
Comparative Effectiveness of GLP-1 Receptor Agonists versus DPP-4 and SGLT2 Inhibitors in Patients with Bronchiectasis and Type 2 Diabetes. GLP-1受体激动剂与DPP-4和SGLT2抑制剂在支气管扩张和2型糖尿病患者中的比较疗效
IF 9.8 1区 医学
Chest Pub Date : 2026-11-13 DOI: 10.1016/j.chest.2026.11.005
Kuo-Ming Liao, Yao-Ming Chuang, Wan-Hsuan Hsu, Chia-Yu Kuo, Jheng-Yan Wu, Bo-Wen Shiau, Konstantinos Kostikas, Gerard J Criner, Chih-Cheng Lai
{"title":"Comparative Effectiveness of GLP-1 Receptor Agonists versus DPP-4 and SGLT2 Inhibitors in Patients with Bronchiectasis and Type 2 Diabetes.","authors":"Kuo-Ming Liao, Yao-Ming Chuang, Wan-Hsuan Hsu, Chia-Yu Kuo, Jheng-Yan Wu, Bo-Wen Shiau, Konstantinos Kostikas, Gerard J Criner, Chih-Cheng Lai","doi":"10.1016/j.chest.2026.11.005","DOIUrl":"https://doi.org/10.1016/j.chest.2026.11.005","url":null,"abstract":"<p><strong>Background: </strong>Bronchiectasis is a chronic inflammatory airway disease with limited disease-modifying therapies. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated anti-inflammatory and immunomodulatory effects, but their impact on bronchiectasis outcomes remains unknown.</p><p><strong>Research question: </strong>Is GLP-1RA use, compared with dipeptidyl peptidase-4 inhibitor (DPP-4i) or sodium-glucose cotransporter-2 inhibitor (SGLT2i) use, associated with better clinical outcomes in patients with bronchiectasis and type 2 diabetes (T2D)?</p><p><strong>Study design and methods: </strong>Using the TriNetX global federated research network, we conducted a retrospective cohort study of patients with bronchiectasis and type 2 diabetes who initiated GLP-1RA therapy between June 1, 2022, and May 30, 2025. We compared clinical outcomes, including all-cause mortality, bronchiectasis exacerbation, acute respiratory failure, and lower respiratory tract infections, with patients receiving DPP-4i) or SGLT2i using propensity score matching to balance baseline characteristics.</p><p><strong>Results: </strong>After propensity score matching, 1,029 patients per group were included in the GLP-1RA versus DPP-4i cohort, and 2,255 patients per group in the GLP-1RA versus SGLT2i cohort. Compared with DPP-4i, GLP-1RA use was associated with significantly lower all-cause mortality (hazard ratio [HR], 0.43; 95% CI, 0.33-0.56) and reduced risks of acute respiratory failure (HR, 0.46; 95% CI, 0.36-0.58) and lower respiratory tract infection (HR, 0.55; 95% CI, 0.46-0.65). Similar benefits were observed compared with SGLT2i for all-cause mortality (HR, 0.49; 95% CI, 0.40-0.60), acute respiratory failure (HR, 0.46; 95% CI, 0.39-0.55), and lower respiratory tract infection (HR, 0.77; 95% CI, 0.68-0.86). Stratified analyses demonstrated consistent mortality benefits across demographic and clinical subgroups, with particularly pronounced effects in obese patients but there was no statistically significant reduction in bronchiectasis exacerbations.</p><p><strong>Interpretation: </strong>Among patients with bronchiectasis and type 2 diabetes, GLP-1RA therapy was associated with significantly lower mortality and reduced respiratory complications compared with DPP-4i or SGLT2i. These findings suggest potential disease-modifying benefits of GLP-1RAs in bronchiectasis beyond glycemic control.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Burden of Chronic Cough in Patients With Interstitial Lung Disease: a US Survey-Based Analysis of Its Effects on Daily Life and Emotional and Social Well-Being. 间质性肺病患者慢性咳嗽的负担:一项基于美国的调查分析其对日常生活、情绪和社会福祉的影响。
IF 9.8 1区 医学
Chest Pub Date : 2026-11-13 DOI: 10.1016/j.chest.2026.11.003
Jeffrey Swigris, Tejaswini Kulkarni, Charlene Watterston, Abbey Nakano, Katherine Barrett, Jessica E Shore
{"title":"The Burden of Chronic Cough in Patients With Interstitial Lung Disease: a US Survey-Based Analysis of Its Effects on Daily Life and Emotional and Social Well-Being.","authors":"Jeffrey Swigris, Tejaswini Kulkarni, Charlene Watterston, Abbey Nakano, Katherine Barrett, Jessica E Shore","doi":"10.1016/j.chest.2026.11.003","DOIUrl":"https://doi.org/10.1016/j.chest.2026.11.003","url":null,"abstract":"<p><strong>Background: </strong>Chronic cough (≥8 weeks) is highly prevalent among patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease (ILD) and imposes significant physical, social, and psychological burden. Research characterizing the burden of chronic cough in patients with IPF and non-IPF ILD from the patient perspective is limited.</p><p><strong>Research question: </strong>What is the multidimensional burden of chronic cough in patients living with IPF or non-IPF ILD?</p><p><strong>Study design and methods: </strong>An online cross-sectional survey was distributed to adults from June to July 2025 via the Pulmonary Fibrosis Foundation's US Community Registry. Eligibility required a self-reported diagnosis of IPF or non-IPF ILD and chronic cough. Multiple-choice and open-text questions spanned six domains: demographics, disease history, cough characteristics, daily life impact, social/emotional and long-term impact, and healthcare experience.</p><p><strong>Results: </strong>A total of 197 participants completed the survey: 75.63% reported a diagnosis of IPF, 21.32% reported non-IPF ILD, and 3.05% were awaiting further ILD diagnosis. Participants reported cough-related interference with daily activities (76.15%) and sleep disruption (79.69%) within the preceding week. Emotional burden was frequently reported: 95.94% of participants had cough-induced worry, 75.13% had depression, sadness, or low mood, and 67.01% reported avoiding social situations because of cough. Additionally, 60.91% of participants reported that chronic cough affected their platonic relationships, and 55.33% reported impact on their ability or desire to maintain physical or intimate relationships. To treat cough, participants reported using an average of 2.7 therapeutic classes historically and 2.0 classes currently, with many reporting limited or no relief.</p><p><strong>Interpretation: </strong>Findings from this US survey of patients with IPF or non-IPF ILD and chronic cough indicate that, among respondents, chronic cough burden manifests physically, psychologically, and psychosocially. Reports of limited relief from available therapies suggest an unmet need in managing chronic cough in this patient population.</p><p><strong>Clinical trial registration: </strong>Not applicable.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How I Do It: An Intensivist's guide to RV Failure and Right Ventricular Assist Devices. 我是怎么做的:一个强化医师关于右心室衰竭和右心室辅助装置的指南。
IF 9.8 1区 医学
Chest Pub Date : 2026-11-13 DOI: 10.1016/j.chest.2026.11.004
Meenakshi Sridhar, Maulin Patel, Gaurav Manek, Junad Chowdhury, Nick Villalobos, Francisco Soto, Arun Jose, Namita Sood, Oksana A Shlobin, Parth Rali, Bindu Akkanti
{"title":"How I Do It: An Intensivist's guide to RV Failure and Right Ventricular Assist Devices.","authors":"Meenakshi Sridhar, Maulin Patel, Gaurav Manek, Junad Chowdhury, Nick Villalobos, Francisco Soto, Arun Jose, Namita Sood, Oksana A Shlobin, Parth Rali, Bindu Akkanti","doi":"10.1016/j.chest.2026.11.004","DOIUrl":"https://doi.org/10.1016/j.chest.2026.11.004","url":null,"abstract":"<p><p>Right ventricular failure (RVF) is a high-mortality form of cardiogenic shock frequently encountered in critical illness and is often underrecognized due to its heterogeneous presentation. This article presents a physiology-driven, stepwise approach to the diagnosis and management of acute RVF using a longitudinal case in the intensive care unit. We highlight practical bedside tools for recognition, including point-of-care ultrasound and invasive hemodynamics, and review targeted strategies for preload optimization, afterload reduction, and contractility support. Special emphasis is placed on airway management, vasoactive medications, and timely escalation to mechanical circulatory support (MCS) in appropriately selected patients. This bedside \"How I Do It\" guide is written for intensivists and pulmonary/critical care clinicians and translates advanced hemodynamic and device concepts into practical decision points for acute care management.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pragmatic Clinical indicators of Tuberculosis Transmission Risk: a Household Contact Cohort Study. 结核病传播风险的实用临床指标:一项家庭接触队列研究。
IF 9.8 1区 医学
Chest Pub Date : 2026-11-11 DOI: 10.1016/j.chest.2026.11.001
Qi Tan, Chuan-Chin Huang, Mercedes C Becerra, Roger Calderon, Carmen Contreras, Leonid Lecca, Judith Jimenez, Rosa Yataco, Jerome T Galea, Zibiao Zhang, Megan B Murray
{"title":"Pragmatic Clinical indicators of Tuberculosis Transmission Risk: a Household Contact Cohort Study.","authors":"Qi Tan, Chuan-Chin Huang, Mercedes C Becerra, Roger Calderon, Carmen Contreras, Leonid Lecca, Judith Jimenez, Rosa Yataco, Jerome T Galea, Zibiao Zhang, Megan B Murray","doi":"10.1016/j.chest.2026.11.001","DOIUrl":"https://doi.org/10.1016/j.chest.2026.11.001","url":null,"abstract":"<p><strong>Background: </strong>Interrupting TB transmission is a priority in high-burden settings. Identifying highly infectious people with TB may guide targeted interventions.</p><p><strong>Research question: </strong>Can readily available clinical characteristics (eg, lung cavitation, cough duration, modified Bandim TB score) indicate the transmission risk in participants with TB?</p><p><strong>Study design and methods: </strong>We conducted an observational cohort study in Lima, Peru, enrolling 4,500 index participants. Of the 4,044 people with microbiologically confirmed TB, 3,109 had at least 1 household contact (HHC), yielding 12,767 HHCs. Index participants underwent chest radiograph and TB symptom assessment, from which we derived a modified Bandim TB score. We assessed HHCs for TB infection at baseline and 6 months, and for incident TB disease over 12 months. We analyzed associations between index participant indicators and TB outcomes in HHCs using modified Poisson regression with generalized estimating equations, adjusting for relevant covariates.</p><p><strong>Results: </strong>Among child HHCs, baseline TB infection risk increased with greater cavitary extent (adjusted trend P = .005) and longer cough duration (adjusted trend P = .002), with similar trends at 6 months. Among cavitation categories, multiple-quadrant involvement was associated with the highest baseline infection risk (adjusted prevalence risk ratio, 1.62; 95% CI, 1.10-2.39), but not with incident disease (adjusted cumulative risk ratio, 1.20; 95% CI, 0.56-2.60). Among cough duration categories, ≥ 56 days showed the highest baseline infection risk (adjusted prevalence risk ratio, 1.59; 95% CI, 1.18-2.13), but not incident disease (adjusted cumulative risk ratio, 1.30; 95% CI, 0.85-1.99). The modified Bandim TB score was not associated with transmission risk.</p><p><strong>Interpretation: </strong>Our results show that in this large household cohort, cavitary extent on chest radiograph and cough duration in people with TB were associated with increased TB transmission risk and showed dose-response relationships with TB infection. These simple, readily available indicators may help target preventive interventions in high-burden settings; however, associations with incident TB remain uncertain.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between temperatures, extreme temperature events, and onset of acute exacerbations of COPD: a time-stratified case-crossover study in China. 温度、极端温度事件和COPD急性加重发作之间的关系:中国的一项时间分层病例交叉研究
IF 9.8 1区 医学
Chest Pub Date : 2026-11-11 DOI: 10.1016/j.chest.2026.10.047
Changyun Zhang, Hailu Zhu, Zhaoyang Pan, Linhong Pang, Zijun Li, Hanchao Cheng, Lian Peng, Junhan Yang, Qi Wang, Yicong Wang, Xinran Shan, Yurui Wu, Ke Huang, Tianjia Guan, Ting Yang, Chen Wang
{"title":"Associations between temperatures, extreme temperature events, and onset of acute exacerbations of COPD: a time-stratified case-crossover study in China.","authors":"Changyun Zhang, Hailu Zhu, Zhaoyang Pan, Linhong Pang, Zijun Li, Hanchao Cheng, Lian Peng, Junhan Yang, Qi Wang, Yicong Wang, Xinran Shan, Yurui Wu, Ke Huang, Tianjia Guan, Ting Yang, Chen Wang","doi":"10.1016/j.chest.2026.10.047","DOIUrl":"https://doi.org/10.1016/j.chest.2026.10.047","url":null,"abstract":"<p><strong>Background: </strong>Non-optimal temperatures and extreme temperature events may trigger acute exacerbations of COPD (AECOPD), but most evidence is admission based, potentially misclassifying exposure timing and obscuring susceptible groups.</p><p><strong>Research question: </strong>Are non-optimal temperature and extreme temperature events associated with AECOPD onset, and which patients are most susceptible?</p><p><strong>Study design and methods: </strong>We used the Acute Exacerbation of Chronic Obstructive Pulmonary Disease Registry (ACURE) data and assigned residential temperature exposure using ERA5-Land, a reanalysis dataset of European Centre for Medium-Range Weather Forecasts. Cold spells (CS) were defined as consecutive days below location-specific low-temperature thresholds, and compound cold spells (CCS) as concurrent daytime and nighttime cold spells. Associations with reported symptom onset were estimated using a time-stratified case-crossover design, conditional logistic regression with distributed lag nonlinear models. Subgroup and cytokine analyses assessed susceptibility and inflammation.</p><p><strong>Results: </strong>Among 5,634 patients with AECOPD (mean age, 69.4 ± 9.5 years; 78.8% male), lower temperature was associated with higher odds of AECOPD onset, whereas higher temperature was not. The strongest associations occurred for CS lasting ≥3 days and CCS lasting ≥2 days over lag 0-3 days, with ORs of 1.84 (95% CI, 1.22-2.78) and 4.31 (95% CI, 2.07-8.97), respectively. Nearly half had delayed admission within 14 days. Using admission rather than onset dates attenuated estimates by 88.8% for CS and 84.8% for CCS. Associations were stronger among older adults, men, smokers, patients with severe AECOPD in the past year or previously diagnosed COPD, and those using combination inhaler in the preceding year. CS were also associated with higher TNF-α, IL-6, and CXCL-11 concentrations.</p><p><strong>Interpretation: </strong>Lower temperature and extreme cold events, particularly CCS, were associated with AECOPD onset. Symptom-onset timing may better capture temperature-related associations than admission timing. These findings highlight the need for targeted cold-weather prevention strategies to reduce AECOPD burden.</p><p><strong>Trial registry: </strong>ClinicalTrials.gov; NO.: NCT02657525.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Ulinastatin in the Treatment of Patients with Sepsis: The ADJUST Trial. 乌司他丁治疗脓毒症患者的疗效和安全性:调整试验。
IF 9.8 1区 医学
Chest Pub Date : 2026-11-06 DOI: 10.1016/j.chest.2026.10.033
Yan Chen, Wei Jiang, Xiangyou Yu, Tongwen Sun, Ruilan Wang, Li Yu, Jing-Ye Pan, Yuan Xu, Xiaozhi Wang, Zhongqing Chen, Hong Zhan, Ping Chang, Gaiqi Yao, Yan-Fen Chai, Jin-Min Peng, Xiao-Yun Hu, Chun-Yao Wang, Run Dong, Shan Li, Li Weng, Bin Du
{"title":"Efficacy and Safety of Ulinastatin in the Treatment of Patients with Sepsis: The ADJUST Trial.","authors":"Yan Chen, Wei Jiang, Xiangyou Yu, Tongwen Sun, Ruilan Wang, Li Yu, Jing-Ye Pan, Yuan Xu, Xiaozhi Wang, Zhongqing Chen, Hong Zhan, Ping Chang, Gaiqi Yao, Yan-Fen Chai, Jin-Min Peng, Xiao-Yun Hu, Chun-Yao Wang, Run Dong, Shan Li, Li Weng, Bin Du","doi":"10.1016/j.chest.2026.10.033","DOIUrl":"https://doi.org/10.1016/j.chest.2026.10.033","url":null,"abstract":"<p><strong>Background: </strong>Urinary trypsin inhibitor (ulinastatin, UTI) has shown potential survival benefits in sepsis; however, conclusive clinical evidence is lacking.</p><p><strong>Research question: </strong>In patients with sepsis, does adjunctive ulinastatin, compared with placebo, reduce 28-day all-cause mortality?</p><p><strong>Study design and methods: </strong>In this multicenter, randomized, double-blind, placebo-controlled trial, adult ICU patients with sepsis meeting Sepsis-3 criteria within 48 hours of admission were randomized (1:1) to receive intravenous UTI (400,000 IU every 8 hours) or placebo, for up to 10 days in addition to standard care. Randomization was stratified by site and septic shock. The primary endpoint was 28-day all-cause mortality. Secondary endpoints included ICU, hospital, and 90-day mortality, and ICU/hospital length of stay.</p><p><strong>Results: </strong>Of 347 patients randomized, 340 (169 UTI, 171 placebo) received intervention and were included in the safety analysis; after 5 post-intervention withdrawals, 335 (165 UTI, 170 placebo) were included in the intention-to-treat analysis. At 28 days, death had occurred in 39 of 165 patients (23.6%) in the UTI group and in 39 of 170 patients (22.9%) in the placebo group (absolute difference, 0.7% [95% CI -8.4% to 9.7%]; P = .98; hazard ratio 1.03, 95% CI 0.66 to 1.61, P = .90). Secondary outcomes were similar in the two groups. Adverse events occurred in 56.8% (96/169) of UTI and 42.7% (73/171) of placebo patients (absolute difference 14.1%, 95% CI 3.6%-24.6%; P = 0.009).</p><p><strong>Interpretation: </strong>In patients with sepsis, adjunctive UTI did not reduce mortality compared with placebo. Routine use of UTI for sepsis is not supported by these findings.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov; https://clinicaltrials.gov; NCT02647554.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149357183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Undernutrition on Post-Tuberculosis Lung-Function: A Prospective Cohort Study. 营养不良对结核病后肺功能的影响:一项前瞻性队列研究。
IF 9.8 1区 医学
Chest Pub Date : 2026-11-05 DOI: 10.1016/j.chest.2026.10.041
Pranay Sinha, Meagan Karoly, Sanjay Gaikwad, Elizabeth Hanna Luke, Nikhil Gupte, Vandana Kulkarni, Neeta Pradhan, Nishi Suryavanshi, Madolyn R Dauphinais, Victoria Zhang, Sriram Selvaraju, Vidya Mave, Amita Gupta, Chandrasekaran Padmapriyadarsini, Mandar Paradkar, Akshay N Gupte
{"title":"The Impact of Undernutrition on Post-Tuberculosis Lung-Function: A Prospective Cohort Study.","authors":"Pranay Sinha, Meagan Karoly, Sanjay Gaikwad, Elizabeth Hanna Luke, Nikhil Gupte, Vandana Kulkarni, Neeta Pradhan, Nishi Suryavanshi, Madolyn R Dauphinais, Victoria Zhang, Sriram Selvaraju, Vidya Mave, Amita Gupta, Chandrasekaran Padmapriyadarsini, Mandar Paradkar, Akshay N Gupte","doi":"10.1016/j.chest.2026.10.041","DOIUrl":"https://doi.org/10.1016/j.chest.2026.10.041","url":null,"abstract":"<p><strong>Background: </strong>Undernutrition is the leading driver of tuberculosis worldwide, yet its effect on the lungs of people who complete treatment is not well defined.</p><p><strong>Research question: </strong>Among adults treated for drug-sensitive pulmonary tuberculosis, is undernutrition associated with worse post-treatment lung function, radiographic severity, exercise capacity and respiratory quality of life, and does systemic inflammation mediate that association?</p><p><strong>Study design and methods: </strong>Adults (≥18 years) with drug-sensitive pulmonary tuberculosis were enrolled at treatment initiation in India. We measured associations of baseline body mass index (BMI), mid-upper arm circumference (MUAC), and premorbid BMI with spirometry, chest radiograph score, six-minute walk distance and St George's Respiratory Questionnaire score. Plasma IFN-γ, TNF-α and IL-6 were measured at baseline and month 2; counterfactual mediation analysis partitioned the effect of undernutrition on lung function into direct and inflammation-mediated components.</p><p><strong>Results: </strong>Of 156 participants analyzed, 76 (48.7%) had a ventilatory defect; 52 (33.3%) had airflow obstruction and 31 (19.9%) had restrictive spirometry. Each 1 kg/m<sup>2</sup> higher baseline BMI was associated with lower odds of any ventilatory defect (adjusted odds ratio [aOR], 0.78; 95% CI, 0.67-0.90), and BMI below 16 kg/m<sup>2</sup> carried five-fold higher odds than BMI ≥18.5 kg/m<sup>2</sup> (aOR, 5.08; 95% CI, 1.76-16.02). MUAC and premorbid BMI showed similar associations. Lower BMI was associated with restrictive spirometry (aOR, 0.74 per kg/m<sup>2</sup>; 95% CI, 0.59-0.89) but not airflow obstruction (aOR, 0.91; 95% CI, 0.80-1.03). Undernourished participants had higher baseline IL-6, which mediated 32% (FEV1) and 49% (FVC) of the association with impaired lung function.</p><p><strong>Interpretation: </strong>Undernutrition before and at treatment initiation is a potentially modifiable determinant of post-treatment lung impairment, with systemic inflammation mediating part of the effect. Nutritional assessment belongs in routine tuberculosis care, and nutritional support should be tested to prevent lung-function impairment in tuberculosis survivors.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pretransplant Pulmonary Hemodynamics, Explant Histology, and Primary Graft Dysfunction after Lung Transplantation for Silicosis. 肺移植后肺血流动力学、外植体组织学和原发性移植物功能障碍。
IF 9.8 1区 医学
Chest Pub Date : 2026-11-05 DOI: 10.1016/j.chest.2026.10.040
Mateo Arnel Mendoza, Alex Tang, Alberto M Marchevsky, Alexander D Yuen, Keerthana Sankar, Jeremy A Falk, Tamana Kaderi, Laura DiChiacchio, Dominick Megna, Pedro Catarino, Michael I Lewis, Reinaldo Rampolla, Yuri Matusov
{"title":"Pretransplant Pulmonary Hemodynamics, Explant Histology, and Primary Graft Dysfunction after Lung Transplantation for Silicosis.","authors":"Mateo Arnel Mendoza, Alex Tang, Alberto M Marchevsky, Alexander D Yuen, Keerthana Sankar, Jeremy A Falk, Tamana Kaderi, Laura DiChiacchio, Dominick Megna, Pedro Catarino, Michael I Lewis, Reinaldo Rampolla, Yuri Matusov","doi":"10.1016/j.chest.2026.10.040","DOIUrl":"https://doi.org/10.1016/j.chest.2026.10.040","url":null,"abstract":"<p><strong>Background: </strong>Silicosis associated with progressive massive fibrosis (PMF) is a major cause of end-stage lung disease among workers in the artificial stone industry. Patients with PMF are increasingly referred for lung transplant (LTx) evaluation and there is emerging evidence of pulmonary hypertension (PH) in patients with advanced PMF.</p><p><strong>Research question: </strong>Among patients with PMF referred for lung transplantation, what is the incidence of PH and what are accompanying histopathologic pulmonary vascular aberrations?</p><p><strong>Study design and methods: </strong>Retrospective single-center cohort study of prospectively-enrolled participants, providing granular data on the invasive hemodynamic profile of patients with silicosis-associated PMF, histopathologic data on pulmonary vascular aberrations, and clinical data on post-transplant complications. Clinical and sociodemographic variables were collected. Explanted lungs from patients with silicosis-associated PMF underwent detailed pulmonary vascular histopathologic review and were descriptively compared with PAH explants. The incidence of primary graft dysfunction (PGD) was evaluated and descriptive analysis performed to provide associations of clinical features and PGD incidence.</p><p><strong>Results: </strong>PH was present in over 95% of 21 patients with silicosis-associated PMF who underwent LTx, with a hemodynamic profile similar to patients transplanted for PAH. . Silicosis explants showed confluent silicotic nodules, extensive fibrosis and hyalinization, obscuration or obliteration of vascular structures, and perivascular fibrohistiocytic infiltrates with extrinsic narrowing. Classic PAH-type arteriolar muscular hypertrophy and plexiform arteriopathy were uncommon. In exploratory comparisons, patients who developed PGD had more frequent pretransplant right ventricular dysfunction (71% vs 21%; risk difference 0.50, 95% CI 0.06-0.75) and a lower median TAPSE/RVSP ratio (0.27 vs 0.39; Hedges' g -0.93, 95% CI -1.88 to 0.02) than in those without PGD.</p><p><strong>Interpretation: </strong>These findings suggest that PH in advanced silicosis with PMF is very common and represents a distinct pulmonary vascular phenotype characterized by extensive fibrotic vascular obliteration rather than the classic arteriopathy seen in PAH.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of removing prior authorization for guideline-concordant maintenance inhaled medications for COPD: a population-based cohort study. 一项基于人群的队列研究:取消指南一致性吸入维持药物治疗COPD的事先授权的影响
IF 9.8 1区 医学
Chest Pub Date : 2026-11-05 DOI: 10.1016/j.chest.2026.10.035
Kate M Johnson, Lucy Cheng, Kevin I Duan, Michael R Law
{"title":"The impact of removing prior authorization for guideline-concordant maintenance inhaled medications for COPD: a population-based cohort study.","authors":"Kate M Johnson, Lucy Cheng, Kevin I Duan, Michael R Law","doi":"10.1016/j.chest.2026.10.035","DOIUrl":"https://doi.org/10.1016/j.chest.2026.10.035","url":null,"abstract":"<p><strong>Background: </strong>Most patients with chronic obstructive pulmonary disease (COPD) do not receive maintenance inhaled therapies in concordance with evidence-based clinical guidelines. Long-acting muscarinic antagonists (LAMA), the recommended first-line therapy, is underused, while inhaled corticosteroids (ICS)/long-acting beta-agonists (LABA) are often used in discordance with clinical guidelines. In July 2020, British Columbia's (BC) universal drug plan removed prior authorization requirements for coverage for LAMA medications and restricted coverage for ICS/LABA.</p><p><strong>Research question: </strong>What is the impact of this policy change on guideline-concordant maintenance inhaled medication use?</p><p><strong>Study design and methods: </strong>In a population-based cohort study using provincial administrative health data, we identified patients with COPD using a validated case definition and followed them from January 2019 (18 months pre-policy) to December 2022 (30 months post-policy). Using interrupted time series analysis, we evaluated the monthly proportion of patients filling a prescription for ICS/LABA and LAMA, mean canisters dispensed, proportion of days covered (PDC), rates of ICS/LABA discontinuation, LAMA (re)initiation, and initiating LAMA as first maintenance therapy. We report absolute differences between observed and counterfactual outcomes at study end.</p><p><strong>Results: </strong>The cohort included 47,583 patients with COPD (mean 71.5 years, 46.5% female, 31.7 months mean follow-up). Thirty months post-policy change, ICS/LABA use decreased by -1.3% (95% CI -2.4, -0.3) and LAMA use increased by 0.8% (95% CI 0.1, 1.6). There was no significant change in the number of ICS/LABA canisters dispensed, PDC or proportion discontinuing ICS/LABA. Mean LAMA canisters dispensed increased by 9.8 per 1,000 patients (95% CI 1.0, 18.7) and PDC increased by 1.5% (95% CI 0.5, 2.4). (Re)initiation of LAMA or initiating LAMA as maintenance therapy increased by 0.2% (95% CI 0.02, 0.3) and 34.8% (95% CI 22.3, 48.6), respectively. Total combined drug costs did not change.</p><p><strong>Interpretation: </strong>Changes to drug coverage in BC were associated with improved guideline-concordant medication use.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Bold and necessary experiments:" The redelegation of authority and responsibility to nurses at the origins of cardiac intensive care. “大胆和必要的实验:”权力和责任的重新授权护士在心脏重症监护的起源。
IF 9.8 1区 医学
Chest Pub Date : 2026-11-04 DOI: 10.1016/j.chest.2026.10.037
Colleen M Farrell
{"title":"\"Bold and necessary experiments:\" The redelegation of authority and responsibility to nurses at the origins of cardiac intensive care.","authors":"Colleen M Farrell","doi":"10.1016/j.chest.2026.10.037","DOIUrl":"https://doi.org/10.1016/j.chest.2026.10.037","url":null,"abstract":"<p><p>Coronary Care Units (CCUs) were at the forefront of the development of intensive care in the 1960s and 1970s. The development of CCUs, and intensive care more broadly, was enabled by the interplay of expanding medical technology and the evolving role of nurses vis-à-vis physicians. This paper examines the history the CCU at New York Hospital, the teaching hospital of Cornell University School of Medicine and School of Nursing, with a particular focus on role of nurses in the unit's success. Drawing from historical archives of New York Hospital and the Cornell University School of Nursing, this paper argues that that nurses were co-creators, alongside physicians, of the NYH CCU, and demonstrates how nurses drew from the NYH CCU experience to expand critical care services at the local and national level, including by advocating for the creation of the NYH medical intensive care unit (MICU), leading a CCU nurse training program to expand regional CCU capability, and contributing expertise to a federally-sponsored national conference on CCUs. A close reading of this history offers lessons and insights as intensive care medicine moves into an uncertain future, chief among them that work of caring for critically ill patients requires the thoughtful integration of new technologies with hands on care.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":""},"PeriodicalIF":9.8,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书